Research publications

Nanoporous metal-phenolic particles as ultrasound imaging probes for hydrogen peroxide

Guo J, Wang X, Henstridge DC, Richardson JJ, Cui J, Sharma A, Febbraio MA, Peter K, de Haan JB, Hagemeyer CE, Caruso F

(2015), Adv Healthc Mater, 4(14), 2170-5

ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling

Goossens S, Radaelli E, Blanchet O, Durinck K, Van der Meulen J, Peirs S, Taghon T, Tremblay CS, Costa M, Farhang Ghahremani M, De Medts J, Bartunkova S, Haigh K, Schwab C, Farla N, Pieters T, Matthijssens F, Van Roy N, Best JA, Deswarte K, Bogaert P, Carmichael C, Rickard A, Suryani S, Bracken LS, Alserihi R, Canté-Barrett K, Haenebalcke L, Clappier E, Rondou P, Slowicka K, Huylebroeck D, Goldrath AW, Janzen V, McCormack MP, Lock RB, Curtis DJ, Harrison C, Berx G, Speleman F, Meijerink JP, Soulier J, Van Vlierberghe P, Haigh JJ

(2015), Nat Commun, 6, 5794

Intravascular leukocyte migration through platelet thrombi: directing leukocytes to sites of vascular injury

Ghasemzadeh M, Hosseini E

(2015), Thromb Haemost, 113(6), 1224-35

Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators

Flierl U, Nero TL, Lim B, Arthur JF, Yao Y, Jung SM, Gitz E, Pollitt AY, Zaldivia MT, Jandrot-Perrus M, Schäfer A, Nieswandt B, Andrews RK, Parker MW, Gardiner EE, Peter K

(2015), J Exp Med, 212(2), 129-37

Novel biological insights in T-cell acute lymphoblastic leukemia

Durinck K, Goossens S, Peirs S, Wallaert A, Van Loocke W, Matthijssens F, Pieters T, Milani G, Lammens T, Rondou P, Van Roy N, De Moerloose B, Benoit Y, Haigh J, Speleman F, Poppe B, Van Vlierberghe P

(2015), Exp Hematol, 43(8), 625-39

The fibrinolytic system-more than fibrinolysis?

Draxler DF, Medcalf RL

(2015), Transfus Med Rev, 29(2), 102-9

Disseminated enteroviral infection associated with obinutuzumab

Dendle C, Gilbertson M, Korman TM, Golder V, Morand E, Opat S

(2015), Emerg Infect Dis, 21(9), 1661-3

Immunohistological description of nongestational ovarian choriocarcinoma in two female mice with conditional loss of Trp53 driven by the Tie2 promoter

Castiglioni V, Farhang Ghahremani M, Goossens S, De Maglie M, Ardizzone M, Haigh JJ, Radaelli E

(2015), Vet Pathol, 52(4), 752-6

Thrombin-induced reactive oxygen species generation in platelets: a novel role for protease-activated receptor 4 and GPIbα

Carrim N, Arthur JF, Hamilton JR, Gardiner EE, Andrews RK, Moran N, Berndt MC, Metharom P

(2015), Redox Biol, 6, 640-7

Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran

Bouchard J, Ghannoum M, Bernier-Jean A, Williamson D, Kershaw G, Weatherburn C, Eris JM, Tran H, Patel JP, Roberts DM

(2015), Clin Toxicol, 53(3), 156-63

Dendritic cell-mediated phagocytosis but not immune activation is enhanced by plasmin

Borg RJ, Samson AL, Au AE, Scholzen A, Fuchsberger M, Kong YY, Freeman R, Mifsud NA, Plebanski M, Medcalf RL

(2015), PLoS One, 10(7), e0131216

Strategies to rescue the consequences of inducible arginase-1 deficiency in mice

Ballantyne LL, Sin YY, St Amand T, Si J, Goossens S, Haenebalcke L, Haigh JJ, Kyriakopoulou L, Schulze A, Funk CD

(2015), PLoS One, 10(5), e0125967

MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide

Asvadi P, Cuddihy A, Dunn RD, Jiang V, Wong MX, Jones DR, Khong T, Spencer A

(2015), Br J Haematol, 169(3), 333-43

ADAMs control inflammation from afar

Andrews RK, Gardiner EE

(2015), J Leukoc Biol, 97(3), 437-8

Modifying chemotherapeutic management of a patient with Burkitt’s lymphoma and pre-existing motor neurone disease

Bortz H, Coutsouvelis J, Corallo CE, Spencer A, Patil S

(2015), J Clin Pharm Ther, 40(4), 483-5

Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice

Lee EM, Yee D, Busfield SJ, McManus JF, Cummings N, Vairo G, Wei A, Ramshaw HS, Powell JA, Lopez AF, Lewis ID, McCall MN, Lock RB

(2015), Haematologica, 100(7), 914-26

Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia

Ling VY, Lee D, McQuilten Z, Avery S, Low M, Cody SH, Nguyen T, McLean C, Gorniak M, Wei A, Ting SB

(2015), Am J Hematol, 90(12), E219-20

Treating pulmonary embolism in Pacific Asia with direct oral anticoagulants

Cohen A, Jeyaindran S, Kim JY, Park K, Sompradeekul S, Tambunan KL, Tran H, Tsai IC, Ward C, Wong R

(2015), Thromb Res, 136(2), 196-207

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia

Wei A, Tan P, Perruzza S, Govindaraj C, Fleming S, McManus J, Avery S, Patil S, Stevenson W, Plebanski M, Spencer A

(2015), Br J Haematol, 169(2), 199-210

Low levels of CD9 coincidental with a novel nonsense mutation in glycoprotein Ibβ in a patient with Bernard-Soulier syndrome

Qiao J, Davis AK, Morel-Kopp MC, Ward CM, Gardiner EE, Andrews RK

(2015), Ann Hematol, 94(12), 2069-71

Publication Details